Alzheimer's Disease Selective Vulnerability and Modeling in Transgenic Mice

被引:27
作者
Goetz, Juergen [1 ]
Schonrock, Nicole [1 ]
Vissel, Bryce [2 ]
Ittner, Lars M. [1 ]
机构
[1] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Sydney, NSW 2006, Australia
[2] St Vincents Hosp, Garvan Inst Med Res, Neural Plast & Regenerat Grp, Neurosci Program, Darlinghurst, NSW 2010, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
Alzheimer's disease; amygdala; amyloid-beta; frontotemporal dementia; hippocampus; neurofibrillary tangles; Parkinson's disease; tau; NEUROFIBRILLARY TANGLE FORMATION; PROLYL ISOMERASE PIN1; PARKINSONS-DISEASE; P301L TAU; FRONTOTEMPORAL DEMENTIA; ANIMAL-MODELS; NEURONAL LOSS; MOUSE MODEL; SUBSTANTIA-NIGRA; CELL LOSS;
D O I
10.3233/JAD-2009-1143
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurodegenerative diseases are characterized by 'hot spots' of degeneration. The regions of primary vulnerability vary between different neurodegenerative diseases. Within these regions, some neurons are lost whereas others that are morphologically indiscriminate survive. The enigma of this selective vulnerability is tightly linked to two fundamental problems in the neurosciences. First, it is not understood how many neuronal cell types make up the mammalian brain; estimates are in the order of more than a thousand. Second, the mechanisms by which some nerve cells undergo functional impairment followed by degeneration while others do not, remain elusive. Understanding the basis for this selective vulnerability has significant implications for understanding the pathogenesis of disease and for developing treatments. Here, we review what is known about selective vulnerability in Alzheimer's disease, frontotemporal dementia, and Parkinson's disease. We suggest, since transgenic animal models of disease reproduce aspects of selective vulnerability, that these models offer a valuable system for future investigations into the physiological basis of selective vulnerability.
引用
收藏
页码:243 / 251
页数:9
相关论文
共 91 条
[1]  
Allen B, 2002, J NEUROSCI, V22, P9340
[2]   SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta [J].
Aumann, T. D. ;
Gantois, I. ;
Egan, K. ;
Vais, A. ;
Tomas, D. ;
Drago, J. ;
Horne, M. K. .
EXPERIMENTAL NEUROLOGY, 2008, 213 (02) :419-430
[3]   TOPOGRAPHIC DISTRIBUTION OF NEUROFIBRILLARY TANGLES AND GRANULOVACUOLAR DEGENERATION IN HIPPOCAMPAL CORTEX OF AGING AND DEMENTED PATIENTS - QUANTITATIVE STUDY [J].
BALL, MJ .
ACTA NEUROPATHOLOGICA, 1978, 42 (02) :73-80
[4]   DOPAMINERGIC INNERVATION OF THE CEREBRAL-CORTEX - UNEXPECTED DIFFERENCES BETWEEN RODENTS AND PRIMATES [J].
BERGER, B ;
GASPAR, P ;
VERNEY, C .
TRENDS IN NEUROSCIENCES, 1991, 14 (01) :21-27
[5]   Genomic analysis of mouse retinal development [J].
Blackshaw, S ;
Harpavat, S ;
Trimarchi, J ;
Cai, L ;
Huang, HY ;
Kuo, WP ;
Weber, G ;
Lee, K ;
Fraioli, RE ;
Cho, SH ;
Yung, R ;
Asch, E ;
Ohno-Machado, L ;
Wong, WH ;
Cepko, CL .
PLOS BIOLOGY, 2004, 2 (09) :1411-1431
[6]   Applying genomics technologies to neural development [J].
Blackshaw, S ;
Livesey, R .
CURRENT OPINION IN NEUROBIOLOGY, 2002, 12 (01) :110-114
[7]  
Braak H, 1998, J NEURAL TRANSM-SUPP, P127
[8]   STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].
BRAAK, H ;
BRAAK, E .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :271-278
[9]  
Braak H, 2000, ANN NY ACAD SCI, V924, P53
[10]   Staging of brain pathology related to sporadic Parkinson's disease [J].
Braak, H ;
Del Tredici, K ;
Rüb, U ;
de Vos, RAI ;
Steur, ENHJ ;
Braak, E .
NEUROBIOLOGY OF AGING, 2003, 24 (02) :197-211